• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

pHLIP(Var7)-P1AP 通过靶向蛋白酶激活受体 1 抑制 MDA-MB-231 三阴性乳腺癌细胞的增殖。

pHLIP(Var7)-P1AP suppresses tumor cell proliferation in MDA-MB-231 triple-negative breast cancer by targeting protease activated receptor 1.

机构信息

Department of Nuclear Medicine, The Affiliated Hospital of Qingdao University, No. 59, Haier Rd., Qingdao, 266100, China.

Intensive Care Unit, The Affiliated Hospital of Qingdao University, Qingdao, China.

出版信息

Breast Cancer Res Treat. 2020 Apr;180(2):379-384. doi: 10.1007/s10549-020-05560-2. Epub 2020 Feb 7.

DOI:10.1007/s10549-020-05560-2
PMID:32034579
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7066270/
Abstract

PURPOSE

Protease-activated receptor 1 (PAR1) is a signaling protein ubiquitously present on the surface of tumor cells, and its homologous protein fragment, PAR1-activating peptide (P1AP), can inhibit protein signal transduction of PAR1/G in tumor cells. pH (Low) insertion peptide (pHLIP) can target the acidic tumor microenvironment (TME) and can be used as an excellent carrier to deliver P1AP to tumor cells for therapeutic purposes.

METHODS

PAR1 expression on the surface of MDA-MB-231 cells and human MCF10A mammary epithelial cells was observed. The binding between fluorescent-labeled pHLIP(Var7)-P1AP and MDA-MB-231 cells under different pH values was analyzed. The effect of pHLIP(Var7)-P1AP on the proliferation of MDA-MB-231 cells was analyzed under the conditions of pH 7.4 and 6.0.

RESULTS

PAR1 was highly expressed on the surface of MDA-MB-231 cells. In an acidic environment (pH 6.0 and 5.0), fluorescent-labeled pHLIP(Var7)-P1AP and MDA-MB-231 cells had a high binding ability, and the binding ability increased with the decrease in pH. In an acidic environment (pH 6.0), pHLIP(Var7)-P1AP significantly inhibited MDA-MB-231 cell proliferation. With 0.5 μg, 1 μg, 2 μg, 4 μg, and 8 μg of pHLIP(Var7)-P1AP, the cell proliferation inhibition rates were 3.39%, 5.27%, 14.29%, 22.14%, and 35.69%, respectively.

CONCLUSION

PAR1 was highly expressed on the surface of MDA-MB-231 cells. pHLIP(Var7)-P1AP can effectively target MDA-MB-231 cells in an acidic environment and inhibit the growth of MDA-MB-231 cells by inhibiting the signal transduction of PAR1/G protein.

摘要

目的

蛋白酶激活受体 1(PAR1)是一种普遍存在于肿瘤细胞表面的信号蛋白,其同源蛋白片段 PAR1 激活肽(P1AP)可以抑制肿瘤细胞中 PAR1/G 蛋白的信号转导。pH(低)插入肽(pHLIP)可以靶向酸性肿瘤微环境(TME),并可用作将 P1AP 递送至肿瘤细胞以用于治疗目的的优秀载体。

方法

观察 MDA-MB-231 细胞和人 MCF10A 乳腺上皮细胞表面的 PAR1 表达。分析不同 pH 值下荧光标记的 pHLIP(Var7)-P1AP 与 MDA-MB-231 细胞的结合情况。在 pH 7.4 和 6.0 条件下分析 pHLIP(Var7)-P1AP 对 MDA-MB-231 细胞增殖的影响。

结果

PAR1 在 MDA-MB-231 细胞表面高度表达。在酸性环境(pH 6.0 和 5.0)下,荧光标记的 pHLIP(Var7)-P1AP 与 MDA-MB-231 细胞具有高结合能力,并且结合能力随 pH 值降低而增加。在酸性环境(pH 6.0)下,pHLIP(Var7)-P1AP 显著抑制 MDA-MB-231 细胞增殖。用 0.5μg、1μg、2μg、4μg 和 8μg 的 pHLIP(Var7)-P1AP,细胞增殖抑制率分别为 3.39%、5.27%、14.29%、22.14%和 35.69%。

结论

PAR1 在 MDA-MB-231 细胞表面高度表达。pHLIP(Var7)-P1AP 可以在酸性环境下有效靶向 MDA-MB-231 细胞,并通过抑制 PAR1/G 蛋白的信号转导抑制 MDA-MB-231 细胞的生长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/285c/7066270/c37f27960995/10549_2020_5560_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/285c/7066270/5bc57c65ab94/10549_2020_5560_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/285c/7066270/f51b6cdbefa7/10549_2020_5560_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/285c/7066270/c37f27960995/10549_2020_5560_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/285c/7066270/5bc57c65ab94/10549_2020_5560_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/285c/7066270/f51b6cdbefa7/10549_2020_5560_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/285c/7066270/c37f27960995/10549_2020_5560_Fig3_HTML.jpg

相似文献

1
pHLIP(Var7)-P1AP suppresses tumor cell proliferation in MDA-MB-231 triple-negative breast cancer by targeting protease activated receptor 1.pHLIP(Var7)-P1AP 通过靶向蛋白酶激活受体 1 抑制 MDA-MB-231 三阴性乳腺癌细胞的增殖。
Breast Cancer Res Treat. 2020 Apr;180(2):379-384. doi: 10.1007/s10549-020-05560-2. Epub 2020 Feb 7.
2
Inhibition of MDA-MB-231 cell proliferation by pHLIP(Var7)-P1AP and SPECT imaging of MDA-MB-231 breast cancer-bearing nude mice using 125I-pHLIP(Var7)-P1AP.pHLIP(Var7)-P1AP 抑制 MDA-MB-231 细胞增殖和 125I-pHLIP(Var7)-P1AP 用于荷 MDA-MB-231 乳腺癌裸鼠的 SPECT 成像。
Nuklearmedizin. 2021 Jun;60(3):240-248. doi: 10.1055/a-1307-1923. Epub 2021 Mar 23.
3
Synthesis and Evaluation of Radioiodine-Labeled pH (Low) Insertion Peptide Variant 7-Like Peptide as a Noninvasive Tumor Microenvironment Imaging Agent in a Mouse MDA-MB-231 Triple-Negative Breast Cancer Model.放射性碘标记的pH(低)插入肽变体7样肽作为小鼠MDA-MB-231三阴性乳腺癌模型中非侵入性肿瘤微环境成像剂的合成与评价
Mol Imaging Biol. 2022 Aug;24(4):570-579. doi: 10.1007/s11307-021-01702-0. Epub 2022 Jan 10.
4
Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment.锝-99m标记的pH(低)插入肽变体7的合成与评估,用于通过靶向肿瘤微环境早期诊断MDA-MB-231三阴性乳腺癌
Front Oncol. 2022 Apr 21;12:869260. doi: 10.3389/fonc.2022.869260. eCollection 2022.
5
An Experimental Study on [I]I-pHLIP (Var7) for SPECT/CT Imaging of an MDA-MB-231 Triple-Negative Breast Cancer Mouse Model by Targeting the Tumor Microenvironment.靶向肿瘤微环境的 [I]I-pHLIP (Var7) 用于 SPECT/CT 成像 MDA-MB-231 三阴性乳腺癌小鼠模型的实验研究
Mol Imaging. 2021 Feb 16;2021:5565932. doi: 10.1155/2021/5565932. eCollection 2021.
6
In Vivo Distribution and Therapeutic Efficacy of Radioiodine-Labeled pH-Low Insertion Peptide Variant 3 in a Mouse Model of Breast Cancer.放射性碘标记的低 pH 插入肽变体 3 在乳腺癌小鼠模型中的体内分布和治疗效果。
Mol Imaging. 2022 Jul 4;2022:7456365. doi: 10.1155/2022/7456365. eCollection 2022.
7
Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates.pHLIP-单甲基澳瑞他汀E偶联物对癌细胞增殖的抑制作用及对乳腺肿瘤的靶向作用
Mol Pharm. 2015 Apr 6;12(4):1250-8. doi: 10.1021/mp500779k. Epub 2015 Mar 13.
8
Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT.外泌体 MMP-1 通过 PAR1 介导的 EMT 转移三阴性乳腺癌的转移潜能。
Breast Cancer Res Treat. 2022 May;193(1):65-81. doi: 10.1007/s10549-022-06514-6. Epub 2022 Mar 7.
9
Prohibitin is involved in the activated internalization and degradation of protease-activated receptor 1.prohibitin参与蛋白酶激活受体1的活化内化和降解过程。
Biochim Biophys Acta. 2014 Jul;1843(7):1393-401. doi: 10.1016/j.bbamcr.2014.04.005. Epub 2014 Apr 13.
10
Down-regulation of PAR1 activity with a pHLIP-based allosteric antagonist induces cancer cell death.基于pHLIP的变构拮抗剂下调PAR1活性可诱导癌细胞死亡。
Biochem J. 2015 Dec 15;472(3):287-95. doi: 10.1042/BJ20150876. Epub 2015 Sep 30.

引用本文的文献

1
Small animal PET imaging with the Ga-labeled pH (low) insertion peptide-like peptide YJL-4 in a triple-negative breast cancer mouse model.在三阴性乳腺癌小鼠模型中使用镓标记的pH(低)插入肽样肽YJL-4进行小动物PET成像。
EJNMMI Radiopharm Chem. 2024 Apr 27;9(1):33. doi: 10.1186/s41181-024-00267-x.
2
Aiming the magic bullet: targeted delivery of imaging and therapeutic agents to solid tumors by pHLIP peptides.瞄准神奇子弹:通过pHLIP肽将成像和治疗剂靶向递送至实体瘤
Front Pharmacol. 2024 Mar 13;15:1355893. doi: 10.3389/fphar.2024.1355893. eCollection 2024.
3
Peptide-drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?

本文引用的文献

1
Protease-Activated Receptor 1 as Therapeutic Target in Breast, Lung, and Ovarian Cancer: Pepducin Approach.蛋白酶激活受体 1 在乳腺癌、肺癌和卵巢癌中的治疗靶点:肽聚糖方法。
Int J Mol Sci. 2018 Jul 31;19(8):2237. doi: 10.3390/ijms19082237.
2
Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors.pHLIP 家族肽用于将货物分子靶向递送至肿瘤的细胞内和细胞外。
Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2811-E2818. doi: 10.1073/pnas.1715350115. Epub 2018 Mar 5.
3
pH-Selective Cytotoxicity of pHLIP-Antimicrobial Peptide Conjugates.
肽-药物偶联物(PDCs):靶向治疗研发的新趋势,是炒作还是希望?
Acta Pharm Sin B. 2023 Feb;13(2):498-516. doi: 10.1016/j.apsb.2022.07.020. Epub 2022 Aug 3.
4
In Vivo Distribution and Therapeutic Efficacy of Radioiodine-Labeled pH-Low Insertion Peptide Variant 3 in a Mouse Model of Breast Cancer.放射性碘标记的低 pH 插入肽变体 3 在乳腺癌小鼠模型中的体内分布和治疗效果。
Mol Imaging. 2022 Jul 4;2022:7456365. doi: 10.1155/2022/7456365. eCollection 2022.
5
Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment.锝-99m标记的pH(低)插入肽变体7的合成与评估,用于通过靶向肿瘤微环境早期诊断MDA-MB-231三阴性乳腺癌
Front Oncol. 2022 Apr 21;12:869260. doi: 10.3389/fonc.2022.869260. eCollection 2022.
6
An Experimental Study on [I]I-pHLIP (Var7) for SPECT/CT Imaging of an MDA-MB-231 Triple-Negative Breast Cancer Mouse Model by Targeting the Tumor Microenvironment.靶向肿瘤微环境的 [I]I-pHLIP (Var7) 用于 SPECT/CT 成像 MDA-MB-231 三阴性乳腺癌小鼠模型的实验研究
Mol Imaging. 2021 Feb 16;2021:5565932. doi: 10.1155/2021/5565932. eCollection 2021.
pH 选择性细胞毒性的 pHLIP-抗菌肽缀合物。
Sci Rep. 2016 Jun 23;6:28465. doi: 10.1038/srep28465.
4
Down-regulation of PAR1 activity with a pHLIP-based allosteric antagonist induces cancer cell death.基于pHLIP的变构拮抗剂下调PAR1活性可诱导癌细胞死亡。
Biochem J. 2015 Dec 15;472(3):287-95. doi: 10.1042/BJ20150876. Epub 2015 Sep 30.
5
A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells.一种智能肿瘤靶向肽-药物偶联物,pHLIP-SS-DOX:在 MCF-7 和 MCF-7/Adr 细胞上的合成和细胞摄取。
Drug Deliv. 2016 Jun;23(5):1734-46. doi: 10.3109/10717544.2015.1028601. Epub 2015 Apr 8.
6
Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates.pHLIP-单甲基澳瑞他汀E偶联物对癌细胞增殖的抑制作用及对乳腺肿瘤的靶向作用
Mol Pharm. 2015 Apr 6;12(4):1250-8. doi: 10.1021/mp500779k. Epub 2015 Mar 13.
7
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment.靶向肿瘤微环境的用于癌症治疗的微小RNA沉默
Nature. 2015 Feb 5;518(7537):107-10. doi: 10.1038/nature13905. Epub 2014 Nov 17.
8
pHLIP-FIRE, a cell insertion-triggered fluorescent probe for imaging tumors demonstrates targeted cargo delivery in vivo.pHLIP-FIRE是一种用于肿瘤成像的细胞插入触发荧光探针,可在体内实现靶向性货物递送。
ACS Chem Biol. 2014 Nov 21;9(11):2545-53. doi: 10.1021/cb500388m. Epub 2014 Sep 10.
9
Antiproliferative effect of pHLIP-amanitin.pHLIP-amanitin 的抗增殖作用。
Biochemistry. 2013 Feb 19;52(7):1171-8. doi: 10.1021/bi301647y. Epub 2013 Feb 8.
10
Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducin.一种穿膜 PAR1 肽抑制动脉血栓形成而不影响止血参数。
Circulation. 2012 Jul 3;126(1):83-91. doi: 10.1161/CIRCULATIONAHA.112.091918. Epub 2012 Jun 15.